Annual ROE
76.55%
-84.51%-52.47%
December 31, 2023
Summary
- As of February 7, 2025, PTCT annual return on equity is 76.55%, with the most recent change of -84.51% (-52.47%) on December 31, 2023.
- During the last 3 years, PTCT annual ROE has risen by +157.97% (+194.02%).
- PTCT annual ROE is now -52.47% below its all-time high of 161.06%, reached on December 31, 2022.
Performance
PTCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
48.38%
-8.65%-15.17%
September 30, 2024
Summary
- As of February 7, 2025, PTCT quarterly return on equity is 48.38%, with the most recent change of -8.65% (-15.17%) on September 30, 2024.
- Over the past year, PTCT quarterly ROE has dropped by -76.54% (-61.27%).
- PTCT quarterly ROE is now -88.66% below its all-time high of 426.59%, reached on September 30, 2022.
Performance
PTCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.5% | -61.3% |
| 3 y3 years | +194.0% | -61.3% |
| 5 y5 years | +251.6% | -61.3% |
PTCT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.5% | +135.3% | -88.7% | +100.5% |
| 5 y | 5-year | -52.5% | +135.3% | -88.7% | +100.5% |
| alltime | all time | -52.5% | +135.3% | -88.7% | +100.5% |
PTC Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 48.38%(-15.2%) |
| Jun 2024 | - | 57.03%(-27.1%) |
| Mar 2024 | - | 78.21%(-21.2%) |
| Dec 2023 | 76.55%(-52.5%) | 99.22%(-20.6%) |
| Sep 2023 | - | 124.92%(-18.6%) |
| Jun 2023 | - | 153.47%(-18.5%) |
| Mar 2023 | - | 188.26%(-28.7%) |
| Dec 2022 | 161.06%(-174.3%) | 264.06%(-38.1%) |
| Sep 2022 | - | 426.59%(-104.6%) |
| Jun 2022 | - | -9218.07%(+1683.4%) |
| Mar 2022 | - | -516.88%(+112.6%) |
| Dec 2021 | -216.75%(+166.2%) | -243.11%(+69.6%) |
| Sep 2021 | - | -143.35%(+50.6%) |
| Jun 2021 | - | -95.17%(+0.0%) |
| Mar 2021 | - | -95.13%(+16.7%) |
| Dec 2020 | -81.42%(+52.9%) | -81.49%(+6.0%) |
| Sep 2020 | - | -76.91%(+1.5%) |
| Jun 2020 | - | -75.81%(+44.7%) |
| Mar 2020 | - | -52.39%(+8.7%) |
| Dec 2019 | -53.24%(+5.4%) | -48.19%(+4.2%) |
| Sep 2019 | - | -46.26%(-12.9%) |
| Jun 2019 | - | -53.14%(-2.0%) |
| Mar 2019 | - | -54.25%(+11.1%) |
| Dec 2018 | -50.51% | -48.85%(+37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -35.48%(+3.1%) |
| Jun 2018 | - | -34.42%(-28.1%) |
| Mar 2018 | - | -47.85%(-16.1%) |
| Dec 2017 | -57.24%(-30.4%) | -57.04%(-28.0%) |
| Sep 2017 | - | -79.17%(+1.6%) |
| Jun 2017 | - | -77.95%(-13.4%) |
| Mar 2017 | - | -89.96%(+7.3%) |
| Dec 2016 | -82.24%(+26.5%) | -83.85%(+0.6%) |
| Sep 2016 | - | -83.39%(+5.8%) |
| Jun 2016 | - | -78.85%(+10.1%) |
| Mar 2016 | - | -71.62%(+10.6%) |
| Dec 2015 | -65.00%(+50.8%) | -64.78%(+13.9%) |
| Sep 2015 | - | -56.85%(+8.2%) |
| Jun 2015 | - | -52.52%(+10.9%) |
| Mar 2015 | - | -47.36%(+11.6%) |
| Dec 2014 | -43.10%(-51.0%) | -42.45%(-3.7%) |
| Sep 2014 | - | -44.08%(+30.2%) |
| Jun 2014 | - | -33.85%(-4.5%) |
| Mar 2014 | - | -35.46%(-37.4%) |
| Dec 2013 | -87.90%(-164.3%) | -56.63%(+13.0%) |
| Sep 2013 | - | -50.13%(-34.5%) |
| Jun 2013 | - | -76.59%(-83.4%) |
| Mar 2013 | - | -461.22%(-437.4%) |
| Dec 2012 | 136.68%(-1155.4%) | 136.68% |
| Dec 2011 | -12.95% | - |
FAQ
- What is PTC Therapeutics annual return on equity?
- What is the all time high annual ROE for PTC Therapeutics?
- What is PTC Therapeutics annual ROE year-on-year change?
- What is PTC Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for PTC Therapeutics?
- What is PTC Therapeutics quarterly ROE year-on-year change?
What is PTC Therapeutics annual return on equity?
The current annual ROE of PTCT is 76.55%
What is the all time high annual ROE for PTC Therapeutics?
PTC Therapeutics all-time high annual return on equity is 161.06%
What is PTC Therapeutics annual ROE year-on-year change?
Over the past year, PTCT annual return on equity has changed by -84.51% (-52.47%)
What is PTC Therapeutics quarterly return on equity?
The current quarterly ROE of PTCT is 48.38%
What is the all time high quarterly ROE for PTC Therapeutics?
PTC Therapeutics all-time high quarterly return on equity is 426.59%
What is PTC Therapeutics quarterly ROE year-on-year change?
Over the past year, PTCT quarterly return on equity has changed by -76.54% (-61.27%)